Studies have shown positive effects of JAK inhibitors in AD, including improved skin barrier function, suppression of pruritus, cutaneous nerve elongation, and impaired differentiation of Th2 cells in response to IL-4 and IL-13 [83-85]. The gene discussed is IL13; the disease is Alzheimer disease.